Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-12 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
09/11/26	NOK 0.3980	-2.09%	2,908,348
06/11/26	NOK 0.4065	-2.98%	3,145,053
05/11/26	NOK 0.4190	-0.36%	1,874,026
04/11/26	NOK 0.4205	+0.36%	2,237,108
03/11/26	NOK 0.4190	-0.59%	1,680,524

Real-time Oslo Bors

More quotes

EPS Estimates

Evolution of Analysts' Estimates - EPS - Lifecare ASA

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Lifecare ASA

Company calendar

Market Closed - Oslo Bors 15:45:00 09/11/2026 GMT			5-day change	1st Jan Change
0.3980 ^NOK	-2.09%		-8.72%	-87.79%

10-26	Lifecare ASA Advances Rapidly Towards Repeatable In-House Implant Manufacturing At New Bergen Facilities	CI
09-29	Lifecare Successfully Manufactures First Functional Implants In-House in Bergen	CI

Market Cap	162M 17.29M 15.39M 14.12M 12.85M 24.21M 1.62B 24.94M 169M 67.48M 867M 64.86M 63.47M 2.71B	P/E 2026 *	-1.14x	P/E 2027 *	-2.49x
Enterprise Value	153M 16.33M 14.54M 13.34M 12.14M 22.87M 1.53B 23.56M 159M 63.74M 819M 61.26M 59.95M 2.56B	EV / Sales 2026 *	153x	EV / Sales 2027 *	-
Free-Float	73.61%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	LIFE	Real-time
CBOE		Real-time
Boerse Muenchen	LFC0	Real-time
Deutsche Boerse AG	LFC0	Delayed
Börse Stuttgart	LFC0	Delayed
CBOE		Real-time

10-26	Lifecare ASA Advances Rapidly Towards Repeatable In-House Implant Manufacturing At New Bergen Facilities	CI
09-29	Lifecare Successfully Manufactures First Functional Implants In-House in Bergen	CI
09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-10	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
08-31	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
08-19	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-19	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-18	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news: Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Price Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

09-30	Lifecare : Mandatory Notification of Trade by Primary Insider	PU
09-29	Lifecare successfully manufactures first functional implants in-house in Bergen	AQ
08-19	Lifecare : Interim Report Q2 2026 Presentation	PU
08-19	LIFE: Lifecare ASA Q2 2026 results	PU
08-12	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ

1 day	-2.09%
1 week	-8.72%
Current month	-8.72%
1 month	-2.09%
3 months	+24.38%
6 months	-1.85%
Current year	-87.79%

1 week	0.39	0.44
1 month	0.38	0.53
Current year	0.27	1.99
1 year	0.27	6.1
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	06/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	31/03/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	29/02/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	25/06/2020
Morten Foros Krohnstad CHM	Chairman	-	07/05/2021
Lutz Heinemann BRD	Director/Board Member	-	19/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-2.09%	-8.72%	-92.07%	-99.29%	17.55M
WUXI APPTEC CO., LTD.	+2.24%	+5.83%	+58.47%	+65.65%	66.7B
ARGENX SE	+4.66%	+5.77%	+16.93%	+82.87%	56.88B
LONZA GROUP AG	-0.60%	+2.36%	+24.32%	+97.19%	56.53B
BEONE MEDICINES AG	+2.55%	+12.69%	+30.43%	+108.45%	46.49B
IQVIA HOLDINGS INC.	+2.58%	+4.31%	+32.49%	+39.59%	44.8B
REVOLUTION MEDICINES, INC.	+4.09%	+4.62%	+228.06%	+845.00%	41.59B
CELLTRION, INC.	-0.47%	+9.60%	+27.53%	+52.88%	35.35B
GENMAB A/S	+3.80%	-6.42%	+98.16%	+68.09%	33.29B
INSMED INCORPORATED	+1.48%	+3.13%	-38.80%	+388.84%	25.1B
Average	+1.82%	+2.28%	+38.55%	+164.93%	41B
Weighted average by Cap.	+2.29%	+3.97%	+53.74%	+173.17%

	2026 *	2027 *
Net sales	1M 107K 94.85K 87.04K 79.18K 149K 10M 154K 1.04M 416K 5.34M 400K 391K 16.7M	-
Net income	-109M -11.61M -10.34M -9.49M -8.63M -16.26M -1.09B -16.75M -113M -45.33M -582M -43.57M -42.64M -1.82B	-67M -7.14M -6.36M -5.83M -5.31M -10M -670M -10.3M -69.71M -27.86M -358M -26.78M -26.21M -1.12B
Net Debt	-9M -959K -854K -783K -713K -1.34M -90.01M -1.38M -9.36M -3.74M -48.08M -3.6M -3.52M -150M	4M 426K 379K 348K 317K 597K 40.01M 615K 4.16M 1.66M 21.37M 1.6M 1.56M 66.8M